Pretransplant Hyponatremia Could Be Associated With a Poor Prognosis After Liver Transplantation

Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. Aim To study the survival rates of recipients who undergo liver transplantation in associatio...

Full description

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 42; no. 10; pp. 4119 - 4122
Main Authors Boin, I.F.S.F, Capel, C, Ataide, E.C, Cardoso, A.R, Caruy, C.A, Stucchi, R.S.B
Format Journal Article Conference Proceeding
LanguageEnglish
Published Amsterdam Elsevier Inc 01.12.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. Aim To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. Methods This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m2 ), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Results Hyponatremic patients displayed shorter survival ( P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Conclusion Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates.
AbstractList Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m(2)), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Hyponatremic patients displayed shorter survival (P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates.
Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. Aim To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. Methods This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m2 ), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Results Hyponatremic patients displayed shorter survival ( P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Conclusion Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates.
INTRODUCTIONPredicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates.AIMTo study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates.METHODSThis retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m(2)), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors.RESULTSHyponatremic patients displayed shorter survival (P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age.CONCLUSIONHyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates.
Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m 2), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Hyponatremic patients displayed shorter survival ( P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates.
Author Boin, I.F.S.F
Caruy, C.A
Capel, C
Ataide, E.C
Cardoso, A.R
Stucchi, R.S.B
Author_xml – sequence: 1
  fullname: Boin, I.F.S.F
– sequence: 2
  fullname: Capel, C
– sequence: 3
  fullname: Ataide, E.C
– sequence: 4
  fullname: Cardoso, A.R
– sequence: 5
  fullname: Caruy, C.A
– sequence: 6
  fullname: Stucchi, R.S.B
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23841958$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21168641$$D View this record in MEDLINE/PubMed
BookMark eNqNkkFvEzEQhS1URNPCX0AWEuK0wWPvbtYckEKAtlIkIlHE0TjeWXDY2MH2Vsq_r7dJoeqJiy37vXkz-jRn5MR5h4S8AjYFBvXbzTQF7eIueIPYTjm7E6YM5BMygWYmCl5zcUImjJVQgCirU3IW44blNy_FM3LKAeqmLmFCfqwCHtJ67RK93O-80yng1mq68EPf0g9I5zF6Y3XCln636RfVdOV9oKvgfzofbaTzLmGgS3uTz-u_aTpZ756Tp53uI7443ufk2-dP14vLYvnl4moxXxamgjoVcq0raUpA3SCTvBIoOy2FNvm_61C3vOokGBSStVyIWQ2yAt7hGlpRMQ7inLw55GYsfwaMSW1tNNjnQdAPUTWczWTmwbLz3cFpgo8xYKd2wW512CtgagSsNuohYDUCHrUMOBe_PLYZ1tus3ZfeE82G10eDjkb3XQ4yNv7ziabMozfZ9_HgwwzlxmJQ0Vh0Blsb0CTVevt_87x_FGN662zu_Bv3GDd-CC5jV6AiV0x9HVdi3AhgORjqmbgFINW39w
CODEN TRPPA8
CitedBy_id crossref_primary_10_1002_lt_25327
crossref_primary_10_1186_1471_2369_14_269
crossref_primary_10_1210_clinem_dgac685
crossref_primary_10_1097_TXD_0000000000001050
crossref_primary_10_1310_hpj4612_s11
crossref_primary_10_1053_j_ajkd_2012_09_019
crossref_primary_10_1007_s10620_012_2276_3
crossref_primary_10_3390_jcm4010066
crossref_primary_10_1002_cld_630
Cites_doi 10.1002/hep.22418
10.1053/j.gastro.2006.02.017
10.1053/j.gastro.2006.02.010
10.1002/hep.22846
10.1056/NEJMe0805570
10.1002/hep.21412
10.1111/j.1478-3231.2009.01982.x
10.1002/lt.21305
ContentType Journal Article
Conference Proceeding
Copyright Elsevier Inc.
2010 Elsevier Inc.
2015 INIST-CNRS
Copyright © 2010 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Elsevier Inc.
– notice: 2010 Elsevier Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2010 Elsevier Inc. All rights reserved.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.transproceed.2010.10.019
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2623
EndPage 4122
ExternalDocumentID 10_1016_j_transproceed_2010_10_019
21168641
23841958
S0041134510016167
1_s2_0_S0041134510016167
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: PIBIC–CNPq
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1~.
1~5
29Q
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
ABBQC
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N9A
O-L
O9-
OAUVE
OK-
OW-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
WH7
X7M
XPP
Y6R
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
08R
AAPBV
AAUGY
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c516t-9ba59c41ea8e09253e9fa93acba5ffead25f91ce390d2337619512feb1d350213
IEDL.DBID .~1
ISSN 0041-1345
IngestDate Fri Oct 25 23:44:43 EDT 2024
Thu Sep 26 17:05:46 EDT 2024
Sat Sep 28 07:55:48 EDT 2024
Sun Oct 22 16:03:44 EDT 2023
Fri Feb 23 02:36:11 EST 2024
Tue Oct 15 22:55:25 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Hydroelectrolytic balance disorder
Hyponatremia
Prognosis
Digestive system
Liver
Homotransplantation
Inorganic element
Medicine
Metabolic disorder
Association
Treatment
Sodium
Surgery
Graft
Preoperative
Liver transplantation
Language English
License CC BY 4.0
Copyright © 2010 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c516t-9ba59c41ea8e09253e9fa93acba5ffead25f91ce390d2337619512feb1d350213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1016/j.transproceed.2010.10.019
PMID 21168641
PQID 820790410
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_820790410
crossref_primary_10_1016_j_transproceed_2010_10_019
pubmed_primary_21168641
pascalfrancis_primary_23841958
elsevier_sciencedirect_doi_10_1016_j_transproceed_2010_10_019
elsevier_clinicalkeyesjournals_1_s2_0_S0041134510016167
PublicationCentury 2000
PublicationDate 2010-12-01
PublicationDateYYYYMMDD 2010-12-01
PublicationDate_xml – month: 12
  year: 2010
  text: 2010-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: United States
PublicationTitle Transplantation proceedings
PublicationTitleAlternate Transplant Proc
PublicationYear 2010
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Ginès, Guevara (bib3) 2008; 48
Londono, Guevara, Rimola (bib9) 2006; 130
Tavakol, Assadi, Frederick (bib6) 2008; 8
Yun, Kim, Benson (bib10) 2009; 49
Angeli, Wong, Watson (bib4) 2006; 44
Biggins, Kim, Terrault (bib7) 2006; 130
Hackworth, Heuman, Sanyal (bib2) 2009; 9
Mascarenhas, Gurakar (bib1) 2009; 5
Boin Ide, Leonardi, Udo (bib8) 2008; 45
Cárdenas, Ginès (bib11) 2008; 359
Cywinski, Mascha, Miller (bib5) 2008; 14
Hackworth (10.1016/j.transproceed.2010.10.019_bib2) 2009; 9
Cárdenas (10.1016/j.transproceed.2010.10.019_bib11) 2008; 359
Cywinski (10.1016/j.transproceed.2010.10.019_bib5) 2008; 14
Yun (10.1016/j.transproceed.2010.10.019_bib10) 2009; 49
Mascarenhas (10.1016/j.transproceed.2010.10.019_bib1) 2009; 5
Ginès (10.1016/j.transproceed.2010.10.019_bib3) 2008; 48
Tavakol (10.1016/j.transproceed.2010.10.019_bib6) 2008; 8
Biggins (10.1016/j.transproceed.2010.10.019_bib7) 2006; 130
Angeli (10.1016/j.transproceed.2010.10.019_bib4) 2006; 44
Boin Ide (10.1016/j.transproceed.2010.10.019_bib8) 2008; 45
Londono (10.1016/j.transproceed.2010.10.019_bib9) 2006; 130
References_xml – volume: 14
  start-page: 59
  year: 2008
  ident: bib5
  article-title: Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function
  publication-title: Liver Transpl
  contributor:
    fullname: Miller
– volume: 130
  start-page: 1135
  year: 2006
  ident: bib9
  article-title: Hyponatremia impairs early post transplantation outcome in patients with cirrhosis undergoing liver transplantation
  publication-title: Gastroenterology
  contributor:
    fullname: Rimola
– volume: 48
  start-page: 1002
  year: 2008
  ident: bib3
  article-title: Hyponatremia in cirrhosis: pathogenesis, clinical significance and management
  publication-title: Hepatology
  contributor:
    fullname: Guevara
– volume: 9
  start-page: 1071
  year: 2009
  ident: bib2
  article-title: Effect of hyponatremia on outcomes following orthotopic liver transplantation
  publication-title: Liver Int
  contributor:
    fullname: Sanyal
– volume: 130
  start-page: 1652
  year: 2006
  ident: bib7
  article-title: Evidence-based incorporation of serum sodium concentration into MELD
  publication-title: Gastroenterology
  contributor:
    fullname: Terrault
– volume: 5
  start-page: 443
  year: 2009
  ident: bib1
  article-title: Recent advances in liver transplantation for the practicing gastroenterologist
  publication-title: Gastroenterol Hepatol
  contributor:
    fullname: Gurakar
– volume: 49
  start-page: 1610
  year: 2009
  ident: bib10
  article-title: Impact of pretransplant hyponatremia on outcome following liver transplantation
  publication-title: Hepatology
  contributor:
    fullname: Benson
– volume: 44
  start-page: 1535
  year: 2006
  ident: bib4
  article-title: Hyponatremia in cirrhosis: results of a patient population survey
  publication-title: Hepatology
  contributor:
    fullname: Watson
– volume: 8
  start-page: 337
  year: 2008
  ident: bib6
  article-title: Pre-transplant meld score and serum sodium can predict post-transplant complications
  publication-title: Am J Transplant
  contributor:
    fullname: Frederick
– volume: 359
  start-page: 1060
  year: 2008
  ident: bib11
  article-title: Predicting mortality in cirrhosis—serum sodium helps
  publication-title: N Engl J Med
  contributor:
    fullname: Ginès
– volume: 45
  start-page: 275
  year: 2008
  ident: bib8
  article-title: The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term
  publication-title: Arq Gastroenterol
  contributor:
    fullname: Udo
– volume: 48
  start-page: 1002
  year: 2008
  ident: 10.1016/j.transproceed.2010.10.019_bib3
  article-title: Hyponatremia in cirrhosis: pathogenesis, clinical significance and management
  publication-title: Hepatology
  doi: 10.1002/hep.22418
  contributor:
    fullname: Ginès
– volume: 130
  start-page: 1135
  year: 2006
  ident: 10.1016/j.transproceed.2010.10.019_bib9
  article-title: Hyponatremia impairs early post transplantation outcome in patients with cirrhosis undergoing liver transplantation
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.02.017
  contributor:
    fullname: Londono
– volume: 130
  start-page: 1652
  year: 2006
  ident: 10.1016/j.transproceed.2010.10.019_bib7
  article-title: Evidence-based incorporation of serum sodium concentration into MELD
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.02.010
  contributor:
    fullname: Biggins
– volume: 45
  start-page: 275
  year: 2008
  ident: 10.1016/j.transproceed.2010.10.019_bib8
  article-title: The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term
  publication-title: Arq Gastroenterol
  contributor:
    fullname: Boin Ide
– volume: 49
  start-page: 1610
  year: 2009
  ident: 10.1016/j.transproceed.2010.10.019_bib10
  article-title: Impact of pretransplant hyponatremia on outcome following liver transplantation
  publication-title: Hepatology
  doi: 10.1002/hep.22846
  contributor:
    fullname: Yun
– volume: 359
  start-page: 1060
  year: 2008
  ident: 10.1016/j.transproceed.2010.10.019_bib11
  article-title: Predicting mortality in cirrhosis—serum sodium helps
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe0805570
  contributor:
    fullname: Cárdenas
– volume: 44
  start-page: 1535
  year: 2006
  ident: 10.1016/j.transproceed.2010.10.019_bib4
  article-title: Hyponatremia in cirrhosis: results of a patient population survey
  publication-title: Hepatology
  doi: 10.1002/hep.21412
  contributor:
    fullname: Angeli
– volume: 9
  start-page: 1071
  year: 2009
  ident: 10.1016/j.transproceed.2010.10.019_bib2
  article-title: Effect of hyponatremia on outcomes following orthotopic liver transplantation
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2009.01982.x
  contributor:
    fullname: Hackworth
– volume: 5
  start-page: 443
  year: 2009
  ident: 10.1016/j.transproceed.2010.10.019_bib1
  article-title: Recent advances in liver transplantation for the practicing gastroenterologist
  publication-title: Gastroenterol Hepatol
  contributor:
    fullname: Mascarenhas
– volume: 14
  start-page: 59
  year: 2008
  ident: 10.1016/j.transproceed.2010.10.019_bib5
  article-title: Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function
  publication-title: Liver Transpl
  doi: 10.1002/lt.21305
  contributor:
    fullname: Cywinski
– volume: 8
  start-page: 337
  year: 2008
  ident: 10.1016/j.transproceed.2010.10.019_bib6
  article-title: Pre-transplant meld score and serum sodium can predict post-transplant complications
  publication-title: Am J Transplant
  contributor:
    fullname: Tavakol
SSID ssj0004243
Score 2.013351
Snippet Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting...
Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing...
INTRODUCTIONPredicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 4119
SubjectTerms Adult
Biological and medical sciences
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Hyponatremia - physiopathology
Liver Transplantation
Liver, biliary tract, pancreas, portal circulation, spleen
Male
Medical sciences
Middle Aged
Preoperative Period
Prognosis
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Survival Rate
Tissue, organ and graft immunology
Title Pretransplant Hyponatremia Could Be Associated With a Poor Prognosis After Liver Transplantation
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0041134510016167
https://dx.doi.org/10.1016/j.transproceed.2010.10.019
https://www.ncbi.nlm.nih.gov/pubmed/21168641
https://search.proquest.com/docview/820790410
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD6ahpCQEIKNS7hUfkB7Wlh9SZo88NBVTOU29aETezNOYmtBLKmS7KEv_HaOnThlAiQk3qq2Ttx8n30-u985BnhtTKYik5iQZSIOhSmSMIszGmpbrF0jRzJnHv98Hi8vxIfL6HIPFj4Xxtoqh7m_n9PdbD28czI8zZNNWdocX0EpFxF1siW2GeUCwx9y-s2Pnc1DMO-co6H9ti886jxenSsg3keK3uZlnV626s6fg9T9jWrx0Zn-zIu_i1IXnM4ewoNBVZJ53_FHsKerAzicV7iivt6SI-J8nm4D_QDunvpXR6u-bvX2mKx3aVjtsWswVrTeHsLXVaP7H_EdgSDL7cbuuTf6ulRkYc_IJqeaeKB1Qb6U3RVRZFXXDVk1tfXylS2Z2-PIySdrBCHr8WqOGY_h4uzderEMh6MZwjyicRemiHCaC6pVoqcpi7hOjUq5yi3yBtnJIpPSXPN0WjDO7V4JKguDgaHgEcoK_gT2q7rSz4BEOsclGJtlWaaEioukELjIQZXBjWYmKQLgHgu56StwSG9N-yZ_RVBaBO1niGAAMw-b9DmmOCvqdhiiraSyZXIqf6NRAG_HlreYKDHI_NOdJ7dYMnYaxZGwpX0CIJ42Esey_YNGVbq-aSWqsVmK3ZkG8LSn064xpXESC_r8P3v3Au6x0ZDzEva75ka_QlnVZRM3biZwZ_7-4_L8J7JHJOk
link.rule.ids 310,311,315,783,787,792,793,4509,23942,23943,24128,25152,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwGP00hhBIaIKNH2Fj-IB2WlgdO2ly4NBVTAW6qYdO7GacxBZBLKmS7NALfzufnTjdBEhI3KIkTpy8Z38vzvNngLdapzLUsfaDlEc-13nsp1FKfWWStSvkSGrN4-cX0eySf7oKr7Zg6ubCGFtl3_d3fbrtrfs9J_3bPFkVhZnjyyllPKRWtkTje3CfG32MpH73c-Pz4IGzzlHfnO4yj1qTV2sziHehovN5GauXSbvz5yj1eCUbfHe6W_Ti76rURqezJ7DTy0oy6Wr-FLZUuQt7kxI_qa_X5IhYo6cdQd-FB6du62jRJa5eH5PlZh5Wc2wLDCmt13vwdVGr7iF-IBJktl6ZQfdaXReSTM0i2eRUEYe0ysmXov1GJFlUVU0WdWXMfEVDJmY9cjI3ThCyHK5mqfEMLs8-LKczv1-bwc9CGrV-ghAnGadKxmqUBCFTiZYJk5mBXiM9g1AnNFMsGeUBY2awBKWFxsiQsxB1BXsO22VVqpdAQpXhN1gwTtNUchnlcc4RRZQZTKtAx7kHzGEhVl0KDuG8ad_FbQSFQdAcQwQ9GDvYhJtkit2iavo22ggqmkCMxG888uD9UPIOFQVGmX-68-EdlgyVRnXETW4fD4ijjcDGbP7QyFJVN41AOTZOsDojD150dNoUpjSKI05f_Wft3sDD2fJ8LuYfLz7vw6NgcOccwHZb36jXqLHa9NC2oV9JDSaC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Transplantation+proceedings&rft.atitle=Pretransplant+Hyponatremia+Could+Be+Associated+With+a+Poor+Prognosis+After+Liver+Transplantation&rft.au=BOIN%2C+I.+F.+S.+F&rft.au=CAPEL%2C+C&rft.au=ATAIDE%2C+E.+C&rft.au=CARDOSO%2C+A.+R&rft.date=2010-12-01&rft.pub=Elsevier&rft.issn=0041-1345&rft.eissn=1873-2623&rft.volume=42&rft.issue=10&rft.spage=4119&rft.epage=4122&rft_id=info:doi/10.1016%2Fj.transproceed.2010.10.019&rft.externalDBID=n%2Fa&rft.externalDocID=23841958
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00411345%2FS0041134510X00124%2Fcov150h.gif